Aether Bio

About:

Aether Bio is a developer of machine learning technology used to re-purpose enzymes in order to create a new compound.

Website: https://www.aetherbio.com

Top Investors: Gaingels, Artis Ventures (AV), SV Angel, Leblon Capital, Unless

Description:

Aether Bio is a developer of machine learning technology used to repurpose enzymes in order to create new compounds. Its technology utilizes machine learning combined with high-throughput robotic laboratories to create an entirely new compound and reinvent the production of previously discovered compounds that enable healthcare institutes to get the chemicals and materials they need that are cheaper and more sustainable. The company's proprietary hardware allows massively parallelized experimentation, generating datasets orders of magnitude larger than the competition.

Total Funding Amount:

$49.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Menlo Park, California, United States

Founded Date:

2017-01-01

Founders:

Pavle Jeremic

Number of Employees:

11-50

Last Funding Date:

2023-08-15

IPO Status:

Private

© 2024 MyAiNote.com